Company & Sponsor Intelligence

University of Rochester

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials10

Recruiting3

Completed6

Countries1

Therapeutic footprint

alzheimersautismdepressionneuro_oncologyother_psychiatryparkinsons

Indexed studies

NCT07290387Tele-Savvy for Latino Caregivers
alzheimers · United StatesNA

NCT00449865NET-PD LS-1 Creatine in Parkinson's Disease
parkinsons · United StatesPHASE3

NCT00844753Atomoxetine, Placebo and Parent Management Training in Autism
autism · United StatesPHASE4

NCT02803749Buspirone in Parkinson's Disease
parkinsons · United StatesPHASE2

NCT00278811Emergency Linkage to Outpatient Psychiatric Services
other_psychiatry · United StatesPHASE1

NCT03681015Wearable Assessments in the Clinic and Home in PD
parkinsons · United StatesCOMPLETED

NCT04390906A Study of Cognitive Changes in Patients Receiving Brain Radiation
neuro_oncology · United StatesACTIVE_NOT_RECRUITING

NCT01984060Feasibility of an Exercise Intervention
depression · United StatesNA

NCT05287620Objective, Passive Assessment of LRRK2 Carriers
parkinsons · United StatesCOMPLETED

NCT07217912Daridorexant to Prevent Post-cardiotomy Delirium
alzheimers · United StatesPHASE2

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →